dsdsa

ngwaahịa

Nnukwu ịdị ọcha 540737-29-9 Tofacitinib citrate maka JAK Pathway Inhibitor

Nkọwa dị mkpirikpi:


  • Ịdị ọcha:≧99.0%
  • Ọkọlọtọ Ogo:Standardkpụrụ Enterprise ma ọ bụ dị ka achọrọ
  • Ike:35Kgs/ọnwa
  • Ndụ nchekwa:Afọ atọ
  • Ngwa:Na-agwọ ọrịa ogbu na nkwonkwo, psoriatic ogbu na nkwonkwo, ankylosing spondylitis na ulcerative colitis.
  • Uru otu:Ahụmahụ mbupụ ahịa otu na ọkachamara ọzụzụ na factory
  • Nkọwa ngwaahịa

    FAQ

    Mkpado ngwaahịa

    Ngwaahịaaha Citrate nke Tofacitinib
    Ụdị okwu (3R,4R) -1- (Cyanoacetyl) -4-methyl-N-methyl-N-1H-pyrrolo [2,3-d] pyrimidin-4-yl-3-piperidinamine 2-hydroxy-1,2,3 - propanetricarboxylate;CP 690500-10;CP 690550-10;(3R,4R) -4-Methyl-3- (methyl-7H-pyrrolo [2,3-d] pyrimidin-4-ylamino) -beta-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate
    CAS Mba. 540737-29-9
    Ọdịdị Gbanyụọ ọcha na ntụ ntụ ọcha
    Usoro ihe omimi C16H20N6OC6H8O7
    Ibu molekụla 504.50
    Ngwa Ọkwa ọgwụ ma ọ bụ ebumnuche nyocha
    Nkwakọ ngwaahịa Dị ka arịrịọ gị si dị
    Nchekwa Chekwaa n'ime akpa siri ike, nke na-enweghị ọkụ n'ebe dị mma

     

    Tofacitinib Citrate (CAS #540737-29-9)

    NGWA

    Ọkọlọtọ

    Nsonaazụ

    Ọdịdị

    Gbanyụọ ọcha na ntụ ntụ ọcha

    Gbanyụọ ntụ ntụ ọcha

    njirimara

    HPLC;IR;HNMR

    Na-akwado

    Solubility

    Soluble na DMSO na 100mg / ml, soluble nke ukwuu na ethanol, obere soluble na mmiri wdg.

    Na-akwado

    Ọnwụ na ihicha

    ≤0.5%

    0.12%

    Ihe fọdụrụ na mgbanye

    ≤0.1%

    0.05%

    Ọla dị arọ

    ≤10ppm

    Na-akwado

    Ihe ndị emetụtara

    Diasteromer (RS+SR) ≤0.1%

    Otu adịghị ọcha ≤0.15%

    Mkpokọta adịghị ọcha ≤1.0%

    0.05%

    0.14%

    0.18%

    Enantiomorphism Isomers

    ≤0.2%

    Na-akwado

    Ihe mgbaze fọdụrụnụ

    Ethanol ≤5000ppm

    Methanol ≤3000ppm

    Toluene ≤890ppm

    Na-akwado

    Citrate ọdịnaya

    36.2% ~ 40%

    37.8%

    Ịdị ọcha

    ≥99.0%

    99.38%

    Nyocha

    60.68% ~ 63.16% nke Tofacitinib INN

    98% ~ 102% nke Tofacitinib Citrate INN

    62.04%

     

    99.12%

    Mmechi: Emebere ya

    Ozi ụlọ ọrụ

    √ Ahụmahụ zuru oke nke oyi akwa na ụlọ ọrụ mmepụta ihe na ndị na-eso ụzọ teknụzụ nwere nkà;
    √ Quality bụ mgbe anyị n'elu echiche, siri ike QC usoro;
    √ 11 afọ nwere ahụmahụ mbupụ ahịa otu;
    √ ụlọ nyocha R&D nọọrọ onwe ya;
    √ Ụlọ ọrụ GMP abụọ bịanyere aka na ogologo oge;
    √ Akụ bara ụba nke ọtụtụ ụlọ ọrụ na-abaghị uru maka ọrụ ahaziri iche;
    √ Ndị otu na-arụ ọrụ nke ọma na ụzọ na-agbanwe agbanwe.
    imgsafSDGSHDASFG

  • Nke gara aga:
  • Osote:

  • Dee ozi gị ebe a ziga anyị ya